Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
National Jewish Health has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters are spread across 3 examiners and 3 art units, so the portfolio presents separate examination environments.
ALABI, OYELEYE A is the busiest examiner, with 1 pending matter. A matter-specific approach is appropriate because no examiner or art unit is shown as handling multiple pending matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALABI, OYELEYE A | 1 | 83.9% | +23.8% |
| PRIEST, JESSICA MARIE | 1 | — | — |
| HAMA, JOANNE | 1 | 25.4% | +40.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044349 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASES OR CONDITIONS RELATED TO INNATE LYMPHOID CELLS | HAMA, JOANNE | 70d |
| 18586007 | Methods of Identifying Atopic Dermatitis and Food Allergies | ALABI, OYELEYE A | — |
| 18412165 | Methods and Compositions for Treating Mucus Obstruction in Severe Asthma | PRIEST, JESSICA MARIE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044349 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASES OR CONDITIONS RELATED TO INNATE LYMPHOID CELLS | HAMA, JOANNE | 70d |
| 18586007 | Methods of Identifying Atopic Dermatitis and Food Allergies | ALABI, OYELEYE A | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| 1642 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18586007 | Methods of Identifying Atopic Dermatitis and Food Allergies | ALABI, OYELEYE A | 1797 | §101§103§112 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18412165 | Methods and Compositions for Treating Mucus Obstruction in Severe Asthma | PRIEST, JESSICA MARIE | 1642 | §102§112 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18044349 | METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASES OR CONDITIONS RELATED TO INNATE LYMPHOID CELLS | HAMA, JOANNE | 1645 | §102§103 | Non-Final OA | 70d | Pending | Mar 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Jewish Health has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Oyeleye A Alabi has the most, with 1 of National Jewish Health's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
